News
Despite his age and an ominous-sounding disease, former President Joe Biden has reason for optimism about his aggressive ...
By Kamal Choudhury (Reuters) -Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S.
Zimlovisertib plus tofacitinib shows greater efficacy than tofacitinib alone in reducing Disease Activity Scores in patients ...
The report, to be released Thursday, is expected to identify the key drivers of chronic childhood illness, such as asthma and ...
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Baseline tumor-infiltrating lymphocytes and positive nodes can help identify women with TMBC at high risk for relapse despite ...
Explore more
Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple ...
Power Grid Corporation of India, DLF, Pfizer, New India Assurance, NLC India, and Gujarat Gas are among 104 companies that ...
3h
24/7 Wall St. on MSNHigh-Yield Dividend Portfolios Outperform: These Are Our 5 Favorite Stock PicksHere are our five favorite high-yield dividend stocks with which you can start your portfolio.
Metro Loft and David Werner’s secured $720 million of construction financing to execute New York City’s largest office-resi ...
China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results